Neoadjuvant chemoradiotherapy for patients with squamous cell carcinoma of the oesophagus

被引：0
|
作者：
Pereira, AD
Gloria, L
Claro, I
Chagas, C
Oliveira, J
Vaz, F
Rodrigues, R
Almeida, JC
Leitao, CN
Almeida, JM
Fernandes, A
Mira, FC
机构：
[1] INST PORTUGUES ONCOL LISBOA,DEPT GASTROENTEROL,LISBON,PORTUGAL
[2] INST PORTUGUES ONCOL LISBOA,DEPT SURG,LISBON,PORTUGAL
[3] INST PORTUGUES ONCOL LISBOA,DEPT RADIOTHERAPY & ONCOL,LISBON,PORTUGAL
来源：
GUT | 1997年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [1] Single Unit Experience of Neoadjuvant Chemoradiotherapy (CROSS) in Patients with Squamous Carcinoma of the Oesophagus
    Enein, Mohamed Aboul
    Qureshi, Asad
    Davies, Andrew
    Baker, Cara
    Kelly, Mark
    Gossage, James
    [J]. BRITISH JOURNAL OF SURGERY, 2018, 105 : 33 - 33
  • [2] Neoadjuvant chemoradiotherapy in carcinoma of the oesophagus.
    Toy, EW
    Crosby, TD
    Bowrey, DJ
    Clark, GW
    Carey, PD
    Maughan, TS
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 : 22 - 22
  • [3] Definitive and neoadjuvant radiochemotherapy of squamous cell carcinoma of the oesophagus
    Fietkau, R
    [J]. ONKOLOGIE, 2004, 27 (01): : 39 - 44
  • [4] Neoadjuvant Chemotherapy Versus Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma
    Nakashima, Yuichiro
    Saeki, Hiroshi
    Hu, Qingjiang
    Tsuda, Yasuo
    Hisamatsu, Yuichi
    Ando, Koji
    Oki, Eiji
    Maehara, Yoshihiko
    [J]. ANTICANCER RESEARCH, 2018, 38 (12) : 6809 - 6814
  • [5] Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
    Chen, Fei
    Qiu, Lingdong
    Mu, Yushu
    Sun, Shibin
    Yuan, Yulong
    Shang, Pan
    Ji, Bo
    Wang, Qifei
    [J]. FRONTIERS IN SURGERY, 2022, 9
  • [6] Prognostic benefit of surgery following chemoradiotherapy for squamous cell carcinoma of the oesophagus
    McGlone, Emma R.
    Khan, Omar A.
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2012, 10 (07) : 341 - 344
  • [7] Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma
    Wang, B. -Y.
    Wu, S. -C.
    Chen, H. -C.
    Hung, W. -H.
    Lin, C. -H.
    Huang, C. -L.
    Chen, H. -S.
    [J]. BRITISH JOURNAL OF SURGERY, 2019, 106 (03) : 255 - 262
  • [8] Definitive Chemoradiotherapy versus neoadjuvant Chemoradiotherapy and Resection for Squamous Cell Carcinoma of the Esophagus
    Schrempf, M.
    Anthuber, M.
    [J]. CHIRURG, 2019, 90 (03): : 239 - 239
  • [9] Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Yu, Yong-kui
    Meng, Fan-Yu
    Wei, Xiu-feng
    Chen, Xian-kai
    Li, Hao-miao
    Liu, Qi
    Li, Can-jun
    Xie, Hou-nai
    Xu, Lei
    Zhang, Rui-xiang
    Xing, Wenqun
    Li, Yin
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02):
  • [10] IS NEOADJUVANT CHEMOTHERAPY COMBINED WITH IMMUNOTHERAPY REALLY BETTER THAN NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA?
    Li, Kexun
    Yang, Jiapeng
    Huang, Ynchao
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02): : e31 - e32
12345